Skip to main content
Top
Literature
2.
go back to reference Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):143–52.CrossRefPubMed Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):143–52.CrossRefPubMed
3.
go back to reference Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948–54.CrossRefPubMed Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948–54.CrossRefPubMed
4.
go back to reference Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.CrossRefPubMed Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.CrossRefPubMed
5.
go back to reference Jolkkonen J, Kwakkel G. Translational hurdles in stroke recovery studies. Transl Stroke Res. 2016;7(4):331–42.CrossRefPubMed Jolkkonen J, Kwakkel G. Translational hurdles in stroke recovery studies. Transl Stroke Res. 2016;7(4):331–42.CrossRefPubMed
7.
go back to reference Kent TA, Mandava P. Embracing biological and methodological variance in a new approach to pre-clinical stroke testing. Transl Stroke Res. 2016;7(4):274–83.CrossRefPubMedPubMedCentral Kent TA, Mandava P. Embracing biological and methodological variance in a new approach to pre-clinical stroke testing. Transl Stroke Res. 2016;7(4):274–83.CrossRefPubMedPubMedCentral
8.
go back to reference Ahnstedt H, McCullough LD, Cipolla MJ. The importance of considering sex differences in translational stroke research. Transl Stroke Res. 2016;7(4):261–73.CrossRefPubMedPubMedCentral Ahnstedt H, McCullough LD, Cipolla MJ. The importance of considering sex differences in translational stroke research. Transl Stroke Res. 2016;7(4):261–73.CrossRefPubMedPubMedCentral
9.
go back to reference Ergul A, Hafez S, Fouda A, Fagan SC. Impact of comorbidities on acute injury and recovery in preclinical stroke research: focus on hypertension and diabetes. Transl Stroke Res. 2016;7(4):248–60.CrossRefPubMedPubMedCentral Ergul A, Hafez S, Fouda A, Fagan SC. Impact of comorbidities on acute injury and recovery in preclinical stroke research: focus on hypertension and diabetes. Transl Stroke Res. 2016;7(4):248–60.CrossRefPubMedPubMedCentral
10.
go back to reference Henninger N, Fisher M. Extending the time window for endovascular and pharmacological reperfusion. Transl Stroke Res. 2016;7(4):284–93.CrossRefPubMed Henninger N, Fisher M. Extending the time window for endovascular and pharmacological reperfusion. Transl Stroke Res. 2016;7(4):284–93.CrossRefPubMed
12.
go back to reference Lapchak PA. Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection. Translational Stroke Research. 2015;6(5):345–54. Lapchak PA. Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection. Translational Stroke Research. 2015;6(5):345–54.
13.
go back to reference Goyal M, Hill MD, Saver JL, Fisher M. Challenges and opportunities of endovascular stroke therapy. Ann Neurol. 2016;79(1):11–7.CrossRefPubMed Goyal M, Hill MD, Saver JL, Fisher M. Challenges and opportunities of endovascular stroke therapy. Ann Neurol. 2016;79(1):11–7.CrossRefPubMed
14.
go back to reference Stroke therapy academic industry roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30(12):2752–8.CrossRef Stroke therapy academic industry roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30(12):2752–8.CrossRef
15.
go back to reference Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40(6):2244–50.CrossRefPubMedPubMedCentral Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40(6):2244–50.CrossRefPubMedPubMedCentral
16.
go back to reference Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012;490(7419):187–91.CrossRefPubMedPubMedCentral Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012;490(7419):187–91.CrossRefPubMedPubMedCentral
17.
go back to reference Lapchak PA, Zhang JH, Noble-Haeusslein LJ. RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl Stroke Res. 2013;4(3):279–85.CrossRefPubMed Lapchak PA, Zhang JH, Noble-Haeusslein LJ. RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl Stroke Res. 2013;4(3):279–85.CrossRefPubMed
18.
go back to reference Lapchak PA. Recommendations and practices to optimize stroke therapy: developing effective translational research programs. Stroke. 2013;44(3):841–3.CrossRefPubMed Lapchak PA. Recommendations and practices to optimize stroke therapy: developing effective translational research programs. Stroke. 2013;44(3):841–3.CrossRefPubMed
19.
go back to reference Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, et al. Good laboratory practice: preventing introduction of bias at the bench. Stroke. 2009;40(3):e50–2.CrossRefPubMed Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, et al. Good laboratory practice: preventing introduction of bias at the bench. Stroke. 2009;40(3):e50–2.CrossRefPubMed
21.
go back to reference Archer DP, Walker AM, McCann SK, Moser JJ, Appireddy RM. Anesthetic neuroprotection in experimental stroke in rodents: a systematic review and meta-analysis. Anesthesiology. 2017;126(4):653-665. Archer DP, Walker AM, McCann SK, Moser JJ, Appireddy RM. Anesthetic neuroprotection in experimental stroke in rodents: a systematic review and meta-analysis. Anesthesiology. 2017;126(4):653-665.
22.
go back to reference Xiong L, Zheng Y, Wu M, Hou L, Zhu Z, Zhang X, et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg. 2003;96(1):233–7. Xiong L, Zheng Y, Wu M, Hou L, Zhu Z, Zhang X, et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg. 2003;96(1):233–7.
23.
go back to reference Danos O, Davies K, Lehn P, Mulligan R. The ARRIVE guidelines, a welcome improvement to standards for reporting animal research. J Gene Med. 2010;12(7):559–60.CrossRefPubMed Danos O, Davies K, Lehn P, Mulligan R. The ARRIVE guidelines, a welcome improvement to standards for reporting animal research. J Gene Med. 2010;12(7):559–60.CrossRefPubMed
25.
go back to reference Group NCRRGW. Animal research: reporting in vivo experiments: the ARRIVE guidelines. J Physiol. 2010;588(Pt 14):2519–21. Group NCRRGW. Animal research: reporting in vivo experiments: the ARRIVE guidelines. J Physiol. 2010;588(Pt 14):2519–21.
26.
go back to reference Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother. 2010;1(2):94–9.CrossRefPubMedPubMedCentral Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother. 2010;1(2):94–9.CrossRefPubMedPubMedCentral
27.
go back to reference McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol. 2010;160(7):1573–6.CrossRefPubMedPubMedCentral McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol. 2010;160(7):1573–6.CrossRefPubMedPubMedCentral
28.
go back to reference Blomme EA. The ARRIVE guidelines: a resource for authors and reviewers to ensure that submissions to the Veterinary Journal meet minimal expectations of completeness, accuracy and transparency. Vet J. 2011;189(3):237–8.CrossRefPubMed Blomme EA. The ARRIVE guidelines: a resource for authors and reviewers to ensure that submissions to the Veterinary Journal meet minimal expectations of completeness, accuracy and transparency. Vet J. 2011;189(3):237–8.CrossRefPubMed
29.
go back to reference Baker D, Lidster K, Sottomayor A, Amor S. Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies. PLoS Biol. 2014;12(1):e1001756.CrossRefPubMedPubMedCentral Baker D, Lidster K, Sottomayor A, Amor S. Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies. PLoS Biol. 2014;12(1):e1001756.CrossRefPubMedPubMedCentral
30.
go back to reference Gulin JE, Rocco DM, Garcia-Bournissen F. Quality of reporting and adherence to ARRIVE guidelines in animal studies for Chagas disease preclinical drug research: a systematic review. PLoS Negl Trop Dis. 2015;9(11):e0004194.CrossRefPubMedPubMedCentral Gulin JE, Rocco DM, Garcia-Bournissen F. Quality of reporting and adherence to ARRIVE guidelines in animal studies for Chagas disease preclinical drug research: a systematic review. PLoS Negl Trop Dis. 2015;9(11):e0004194.CrossRefPubMedPubMedCentral
32.
go back to reference Pennypacker KR, Bix G, Fraser JF. Correcting the trajectory of stroke therapeutic research. Transl Stroke Res. 2017;8(1):65–6.CrossRefPubMed Pennypacker KR, Bix G, Fraser JF. Correcting the trajectory of stroke therapeutic research. Transl Stroke Res. 2017;8(1):65–6.CrossRefPubMed
34.
go back to reference Boltze J, Wagner DC, Henninger N, Plesnila N, Ayata C. Phase III preclinical trials in translational stroke research: community response on framework and guidelines. Transl Stroke Res. 2016;7(4):241–7.CrossRefPubMedPubMedCentral Boltze J, Wagner DC, Henninger N, Plesnila N, Ayata C. Phase III preclinical trials in translational stroke research: community response on framework and guidelines. Transl Stroke Res. 2016;7(4):241–7.CrossRefPubMedPubMedCentral
Metadata
Title
Translational Stroke Research Guideline Projections: The 20/20 Standards
Authors
Paul A. Lapchak
John H. Zhang
Publication date
01-02-2018
Publisher
Springer US
Published in
Translational Stroke Research / Issue 1/2018
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-017-0534-6

Other articles of this Issue 1/2018

Translational Stroke Research 1/2018 Go to the issue